According to GlobalData’s medical device pipeline database, 19 Insulin Pens devices are in various stages of development globally. GlobalData’s report Insulin Pens provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, 11 are in active development, while the remaining eight are in an inactive stage of development. There are two products in the early stages of development, and the remaining nine are in the late stages of development.
An insulin pen is used to inject insulin for the treatment of diabetes. An insulin pen is composed of an insulin cartridge (integrated or bought separately) and a dial to measure the dose and is used with disposable pen needles to deliver the dose. One unit refers to One insulin pen.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Insulin Pens pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Insulin Pens devices. Overall, most of these Insulin Pens pipeline devices are being developed by private entities.
Key players involved in the active development of Insulin Pens include Eli Lilly and Co, Ypsomed, Zealand Pharma, Abbott Diabetes Care, Becton Dickinson and Co, Bigfoot Biomedical, Biocon, Cambridge Consultants, Companion Medical and Emperra GmbH E-Health Technologies.
For a complete picture of the developmental pipeline for Insulin Pens devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.